Sign In
Buy HIMS
$28.01
+0.500 (+1.82%)
At Close: Jun 04, 2026
Hims & Hers: GLP-1 Strategy Is On Dubious Grounds
01:00pm, Wednesday, 06'th Aug 2025
Hims & Hers Health showed a sharper-than-expected revenue hiccup in Q2, sending the stock down. The results reflect GLP-1 concerns. Hims & Hers' GLP-1 strategy is now on dubious grounds after Novo Nor
Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
12:00pm, Wednesday, 06'th Aug 2025
LOS ANGELES , Aug. 6, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Hims & Hers Health, Inc. ("Hims" or the "Company") (NYSE: HIMS) have opport
NEW YORK , Aug. 6, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). Such investor
Diagnosis: Hims & Hers' August Price Dip Is an Opportunity to Buy
08:42am, Wednesday, 06'th Aug 2025
Hims & Hers' NYSE: HIMS August price dip is an opportunity to buy, but investors shouldn't rush to get into this healthcare stock. Forces in play, including high short interest and tepid analyst invol
These Are the Smartest Growth Stocks to Invest $1,000 in Today
07:05am, Wednesday, 06'th Aug 2025
Growth stocks abound, and in every market environment, there are opportunities for every investor. If you have $1,000 to put to work in the stock market after accounting for all immediate and necessar
NEW YORK and NEW ORLEANS, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they h
Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Marion Passmore Encourage Investors Who Suffered Losses In Hims To Contact Them To Discuss Their Options
Gibbs Mura Reminds Hims & Hers Health, Inc. (NYSE: HIMS) Investors of Opportunity to Join a Class Action Lawsuit Seeking Recovery
07:15pm, Tuesday, 05'th Aug 2025
OAKLAND, Calif.--(BUSINESS WIRE)---- $HIMS #Classaction--Gibbs Mura reminds investors that a class action lawsuit has been filed on behalf of Hims & Hers Health, Inc. investors.
Stock Market Today: Hims & Hers Tumbles 12% on Revenue Miss Despite 73% Growth
06:45pm, Tuesday, 05'th Aug 2025
Hims & Hers Health Inc. (HIMS -12.42%) fell 12.36% to $55.52, with volume spiking to nearly 104 million shares--more than twice its three-month average. The stock now trades nearly 24% below its recen
Investors can contact the law firm at no cost to learn more about recovering their losses
NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 a
Shareholders of Hims & Hers Health, Inc. Should Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights – HIMS
04:17pm, Tuesday, 05'th Aug 2025
NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities
Wait Out The GLP-1 Storm - Buy The Hims And Hers Post-Earnings Dip
01:02pm, Tuesday, 05'th Aug 2025
Hims and Hers faced a short-term revenue dip due to regulatory changes and GLP-1 customer offboarding, but core growth remains strong. Subscriber numbers surged 31% quarter-over-quarter, and product d
HIMS Stock Plunges Following Q2 Earnings Miss, Gross Margin Down
12:41pm, Tuesday, 05'th Aug 2025
Hims & Hers misses second-quarter 2025 EPS and revenue estimates as gross margin narrows, despite strong online sales and subscriber growth.
Weighing HIMS GLP-1 Trends, NVO Partnership & Other Businesses
12:00pm, Tuesday, 05'th Aug 2025
Michael Cherny sees opportunity for Hims & Hers (HIMS), as long as it can overcome headwinds facing its non-weight loss businesses. He argues the stock hasn't traded on fundamentals and weighs heavily
